Publicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (46)

2024

  1. Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience

    Archivos de Bronconeumologia, Vol. 60, Núm. 1, pp. 10-15

2023

  1. Integration of longitudinal deep-radiomics and clinical data improves the prediction of durable benefits to anti-PD-1/PD-L1 immunotherapy in advanced NSCLC patients

    Journal of Translational Medicine, Vol. 21, Núm. 1

  2. Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer

    EMBO Reports, Vol. 24, Núm. 8

2022

  1. Deep learning-based lesion subtyping and prediction of clinical outcomes in COVID-19 pneumonia using chest CT

    Scientific Reports, Vol. 12, Núm. 1

  2. Deep-learning characterization and quantification of COVID-19 pneumonia lesions from chest CT images

    Progress in Biomedical Optics and Imaging - Proceedings of SPIE

  3. YES1 Is a Druggable Oncogenic Target in SCLC

    Journal of Thoracic Oncology, Vol. 17, Núm. 12, pp. 1387-1403

2021

  1. Delta-radiomics signature for prediction of survival in advanced nsclc patients treated with immunotherapy

    Proceedings - International Symposium on Biomedical Imaging

  2. Natural Course of the Diffusing Capacity of the Lungs for Carbon Monoxide in COPD: Importance of Sex

    Chest, Vol. 160, Núm. 2, pp. 481-490

  3. Nocturnal hypoxemia and CT determined pulmonary artery enlargement in smokers

    Journal of Clinical Medicine, Vol. 10, Núm. 3, pp. 1-12

2020

  1. Design and implementation of predictive models based on radiomics to assess response to immunotherapy in non-small-cell lung cancer

    XXXVIII Congreso Anual de la Sociedad Española de Ingeniería Biomédica. CASEIB 2020: Libro de actas

2019

  1. Corticosteroides inhalados y cáncer de pulmón en la EPOC

    Archivos de bronconeumologia

  2. Inhaled Corticosteroids and Lung Cancer in COPD

    Archivos de Bronconeumologia

  3. New evidence on the chemoprevention of inhaled steroids and the risk of lung cancer in COPD

    European Respiratory Journal, Vol. 53, Núm. 6

  4. Obstructive sleep apnea and nocturnal hypoxemia are associated with an increased risk of lung cancer

    Sleep Medicine, Vol. 63, pp. 41-45

  5. Rationale and Study Design for an Individualized Perioperative Open Lung Ventilatory Strategy in Patients on One-Lung Ventilation (iPROVE-OLV)

    Journal of Cardiothoracic and Vascular Anesthesia, Vol. 33, Núm. 9, pp. 2492-2502

  6. Sleep disordered breathing and nocturnal hypoxemia are very prevalent in a lung cancer screening population and may condition lung cancer screening findings: results of the prospective Sleep Apnea In Lung Cancer Screening (SAILS) study

    Sleep Medicine, Vol. 54, pp. 181-186

  7. Sleep disordered breathing is highly prevalent in patients with lung cancer: Results of the sleep apnea in lung cancer study

    Respiration, Vol. 97, Núm. 2, pp. 119-124

  8. Stromal markers of activated tumor associated fibroblasts predict poor survival and are associated with necrosis in non-small cell lung cancer

    Lung Cancer, Vol. 135, pp. 151-160

2018

  1. A multicentre, randomized controlled trial of telehealth for the management of COPD

    Respiratory Medicine, Vol. 144, pp. 74-81

  2. Changes and Clinical Consequences of Smoking Cessation in Patients With COPD: A Prospective Analysis From the CHAIN Cohort

    Chest, Vol. 154, Núm. 2, pp. 274-285